Efficacy and safety of two different rG-CSF preparations in the treatment of patients with severe congenital neutropenia

British Journal of Haematology

Volumn 126, Issue 1, 2004, Pages 127-132

  Carlsson, Göran ^a,d   Åhlin, Anders ^b   Dahllöf, Göran ^c   Elinder, Göran ^b   Henter, Jan Inge ^a   Palmblad, Jan ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b SACHS CHILDREN S HOSPITAL   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d SUNDERBY HOSPITAL   (Sweden)

Author keywords

Filgrastim; Glycosylation; Granulocyte colony stimulating factor; Lenograstim; Severe congenital neutropenia

Indexed keywords

RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADOLESCENT; ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ACTIVITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; GINGIVA BLEEDING; HOSPITAL ADMISSION; HUMAN; MALE; NEUTROPENIA; NEUTROPHIL; PERIODONTAL DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; STATISTICAL SIGNIFICANCE;

CHILD, PRESCHOOL; CROSS-OVER STUDIES; FEMALE; FILGRASTIM; GINGIVITIS; GRANULOCYTE COLONY STIMULATING FACTOR, RECOMBINANT; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; INFANT; LEUKOCYTE COUNT; MALE; NEUTROPENIA; RECOMBINANT PROTEINS;

EID: 3042838746     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2004.05008.x     Document Type: Article

References (24)

1. de Arriba, F., Lozano, M.L., Ortuno, F., Heras, I., Moraleda, J.M. & Vicente, V. (1997) Prospective randomized study comparing the efficacy of bioequivalent doses of glycosylated and nonglycosylated rG-CSF for mobilizing peripheral blood progenitor cells. British Journal of Haematology, 96, 418-420.
2. Axelsson, P. & Lindhe, J. (1975) Effect of fluoride on gingivitis and dental caries in a preventive program based on plaque control. Community Dentistry and Oral Epidemiology, 3, 156-160.
3. Bönig, H., Silbermann, S., Weller, S., Kirschke, R., Körholz, D., Janssen, G., Göbel, U. & Nürnberger, W. (2001) Glycosylated vs non-glycosylated colony-stimulating factor (G-CSF) - results of a prospective randomised monocentre study. Bone Marrow Transplantation, 28, 259-264.
4. Bonilla, M.A., Dale, D., Zeidler, C., Last, L., Reiter, A., Ruggeiro, M., Davis, M., Koci, B., Hammond, W., Gillio, A. & Weite, K. (1994) Long-term safety of treatment with recombinant human granulocyte colony-stimulating factor (r-metHuG-CSF) in patients with severe congenital neutropenias. British Journal of Haematology, 88, 723-730.
5. Carlsson, G. & Fasth, A. (2001) Infantile genetic agranulocytosis, morbus Kostmann: presentation of six cases from the original 'Kostmann family' and a review. Acta Paediatrica, 90, 757-764.
6. Donadieu, J., Boutard, P., Tchernia, G., Oster, G., Gordon-Smith, E.C., Philippe, N., Le Gall, E., Nivelon, J.-L., Dopfer, R., Babin-Boilletot, A., Coulombel, L., Pocidalo, M.A., Yver, A. & Griscelli, C. (1994) A phase II study of recombinant human granulocyte-colony stimulating factor (rHuG-CSF, lenograstim) in the treatment of agranulocytosis in children. Nouvelle Revue Francaise d'Hématolologie, 36, 441-448.
7. Donadieu, J., Boutard, P., Bernatowska, E., Tchernia, G., Couillaud, G., Philippe, N. & Le Gall, E. (1997) A European phase II study of recombinant human granulocyte-colony stimulating factor (lenograstim) in the treatment of severe chronic neutropenia in children. European Journal of Paediatrics, 156, 693-700.
8. Freedman, M.H., Bonilla, M.A., Fier, C., Bolyard, A.A., Scarlata, D., Boxer, L.A., Brown, S., Cham, B., Kannourakis, G., Kinsey, S.E., Mori, P.G., Cottle, T., Weite, K. & Dale, D.C. (2000) Myelodysplasia syndrome and acute myeloid leukemia in patients with congenital neutropenia receiving G-CSF therapy. Blood, 96, 429-436.
9. Fukuda, M.N., Sasaki, H., Lopez, L. & Fukuda, M. (1989) Survival of recombinant erythropoietin in the circulation: the role of carbohydrates. Blood, 73, 84-89.
10. Höglund, M. (1998) Glycosylated and non-glycosylated recombinant human granulocyte colony-stimulating factor (rhG-CSF) - what is the difference? Medical Oncology, 15, 229-233.
11. + cells by glycosylated and nonglycosylated G-CSF in healthy volunteers - a comparative study. European Journal of Haematology, 59, 177-183.
12. Kostmann, R. (1956) Infantile genetic agranulocytosis. Acta Paediatrica Scandinavica, 45(Suppl. 105), 1-78.
13. Kostmann, R. (1975) Infantile genetic agranulocytosis. Acta Paediatrica Scandinavica, 64, 362-368.
14. Martin-Christin, F. (2001) Granulocyte colony stimulating factors: How different are they? How to make a decision? Anticancer Drugs, 12, 185-191.
15. Nissen, C. (1994) Glycosylation of recombinant human granulocyte colony stimulating factor: implications for stability and potency. European Journal of Cancer, 30A(Suppl. 3), S12-S14.
16. Oh-eda, M., Hasegawa, M., Hattori, K., Kuboniwa, H., Kojima, T., Orita, T., Tomonou, K., Yamazaki, T. & Ochi, N. (1990) O-linked sugar chain of human granulocyte colony-stimulating factor protects it against polymerization and denaturation allowing it to retain its biological activity. The Journal of Biological Chemistry, 265, 11432-11435.
17. Ono, M. (1994) Physicochemical and biochemical characteristics of glycosylated recombinant human granulocyte colony-stimulating factor (lenograstim). European Journal of Cancer, 30A(Suppl. 3), S7-S11.
18. Pütsep, K., Carlsson, G., Boman, H.G. & Andersson, M. (2002) Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study. Lancet, 360, 1144-1149.
19. Querol, S., Cancelas, I.A., Amat, L., Capmany, G. & Garcia, J. (1999) Effect of glycosylation of recombinant human granulocyte colony-stimulating factor on expansion cultures of umbilical cord blood CD34+ cells. Haematologica, 84, 493-498.
20. Rousselot, P. (1997) Lenograstim (glycosylated rHuG-CSF) or filgrastim (r-metHuG-CSF): a difficult choice? Hématologie, 3, 561-564.
21. Watts, M.J., Addison, I., Long, S.G., Hartley, S., Warrington, S., Boyce, M. & Linch, D.C. (1997) Crossover study of the haematological effects and pharmacokinetics of glycosylated and non-glycosylated G-CSF in healthy volunteers. British Journal of Haematology, 98, 474-479.
22. Welte, K. & Dale, D. (1996) Pathophysiology and treatment of severe chronic neutropenia. Annual Hematology, 72, 158-165.
23. van Winkelhoff, A.J., Schouten-van Meeteren, A.Y.N., Baart, J.A. & Vandenbroucke-Grauls, C.M.J.E. (2000) Microbiology of destructive periodontal disease in adolescent patients with congenital neutropenia. Journal of Clinical Periodontology, 27, 793-798.
24. Zeidler, C., Boxer, L., Dale, D.C., Freedman, M.H., Kinsey, S. & Welte, K. (2000) Management of Kostmann syndrome in the G-CSF era (Review). British Journal of Haematology, 109, 490-495.